key: cord-0976476-isiq47ih authors: Smits, Nathan; Rasmussen, Jay; Bodea, Gabriela O.; Amarilla, Alberto A.; Gerdes, Patricia; Sanchez-Luque, Francisco J.; Ajjikuttira, Prabha; Modhiran, Naphak; Liang, Benjamin; Faivre, Jamila; Deveson, Ira W.; Khromykh, Alexander A.; Watterson, Daniel; Ewing, Adam D.; Faulkner, Geoffrey J. title: No evidence of human genome integration of SARS-CoV-2 found by long-read DNA sequencing date: 2021-07-28 journal: Cell Rep DOI: 10.1016/j.celrep.2021.109530 sha: 612d1d1eaa027bff0d98031af2b603bc36b2afca doc_id: 976476 cord_uid: isiq47ih A recent study proposed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) hijacks the LINE-1 (L1) retrotransposition machinery to integrate into the DNA of infected cells. If confirmed, this finding could have significant clinical implications. Here, we apply deep (>50×) long-read Oxford Nanopore Technologies (ONT) sequencing to HEK293T cells infected with SARS-CoV-2, and do not find the virus integrated into the genome. By examining ONT data from separate HEK293T cultivars, we completely resolve 78 L1 insertions arising in vitro in the absence of L1 overexpression systems. ONT sequencing applied to hepatitis B virus (HBV) positive liver cancer tissues located a single HBV insertion. These experiments demonstrate reliable resolution of retrotransposon and exogenous virus insertions via ONT sequencing. That we find no evidence of SARS-CoV-2 integration suggests such events are, at most, extremely rare in vivo, and therefore are unlikely to drive oncogenesis or explain post-recovery detection of the virus. . SARS-CoV-2 does not encode a reverse transcriptase (RT) and therefore is not expected to integrate into genomic DNA as part of its life cycle. This assumption is of fundamental importance to the accurate diagnosis and potential long-term clinical consequences of SARS-CoV-2 infection, as demonstrated by other viruses known to incorporate into genomic DNA, such as human immunodeficiency virus 1 (HIV-1) and hepatitis B virus (HBV) (Bill and Summers, 2004; Fujimoto et al., 2012; Jiang et al., 2012; Nagaya et al., 1987) . Notably, a recent work by Zhang et al. reported potential evidence of SARS-CoV-2 integration into the genome of infected human cells (Zhang et al., 2021) . Prior analyses of mammalian genome sequences, as well as in vivo and in vitro experimental data, indicate single-stranded RNA viruses can act as templates for endogenous RTs (Belyi et al., 2010; Feschotte and Gilbert, 2012; Geuking et al., 2009; Horie et al., 2010; Kawasaki et al., 2021; Klenerman et al., 1997) . These studies provide a conceptual basis to further investigate genomic integration of SARS-CoV-2, as pursued by Zhang et al.. LINE-1 (L1) retrotransposons reside in all mammalian genomes (Kazazian and Moran, 2017) . In humans, L1 transcribes a bicistronic mRNA encoding two proteins, ORF1p and ORF2p, essential to L1 mobility (Moran et al., 1996) . ORF2p possesses endonuclease (EN) and RT activities, and exhibits strong cis preference for reverse transcription of L1 mRNA (Doucet et al., 2015; Garcia-Perez et al., 2007; Kulpa and Moran, 2006; Monot et al., 2013; Moran et al., 1996; Wei et al., 2001) . Nonetheless, the L1 protein machinery can trans mobilise polyadenylated cellular RNAs, especially those produced by Alu and SINE-VNTR-Alu (SVA) retrotransposons, but also including protein-coding gene mRNAs (Dewannieux et al., 2003; Esnault et al., 2000; Garcia-Perez et al., 2007; Hancks et al., 2011; Raiz et al., 2012) . Somatic L1 mobilisation in cis is observed in embryonic cells, the neuronal lineage, and various cancers (Evrony et al., 2015; Feusier et al., 2019; Rodriguez-Martin et al., 2020; Sanchez-Luque et al., 2019; Schauer et al., 2018; Scott et al., 2016) . By contrast, somatic L1mediated trans mobilisation is apparently rare in vivo (Evrony et al., 2015; Rodriguez-Martin et al., 2020; Sanchez-Luque et al., 2019) and is likely repressed by various mechanisms (Ahl et al., 2015; Deniz et al., 2019; Doucet et al., 2015; Ewing et al., 2020; Sanchez-Luque et al., 2019) . While Alu and, to a lesser extent, SVA are readily mobilised in cultured cell assays by L1 proteins, the same machinery produces less than one non-retrotransposon cellular RNA insertion for every 2000 L1 insertions (Dewannieux et al., 2003; Hancks et al., 2011; J o u r n a l P r e -p r o o f al., 2001) . Both cis and trans L1-mediated insertions incorporate target site duplications (TSDs) and a 3′ polyA tract, and integrate at the degenerate L1 EN motif 5′-TTTT/AA (Dewannieux et al., 2003; Esnault et al., 2000; Garcia-Perez et al., 2007; Gilbert et al., 2005; Hancks et al., 2009; Jurka, 1997; Moran et al., 1996; Raiz et al., 2012) . These sequence hallmarks can together discriminate artifacts from genuine insertions (Faulkner and Billon, 2018) . In their work, Zhang et al. overexpressed L1 in HEK293T cells, infected these with SARS-CoV-2, and identified DNA fragments of the virus through PCR amplification. These results, alongside other less direct (Kazachenka and Kassiotis, 2021; Yan et al., 2021) analyses, were interpreted as evidence of SARS-CoV-2 genomic integration. Crucially, Zhang et al. then detected 63 putative SARS-CoV-2 integrants by Oxford Nanopore Technologies (ONT) long-read sequencing. Of these, only a single integrant on chromosome X was spanned by an ONT read aligned to one locus, and was flanked by potential TSDs ( Figure 1A) . However, this SARS-CoV-2 integrant did not incorporate a 3′ polyA tract, as is expected for an L1-mediated insertion, and involved an unusual 28kb internal deletion of the SARS-CoV-2 sequence. Overall, the SARS-CoV-2 integrants reported by Zhang et al. were 26-fold enriched in exons, despite the L1 EN showing no preference for these regions (Flasch et al., 2019; Sultana et al., 2019) . Zhang et al. also used Illumina short-read sequencing to map putative SARS-CoV-2 integration junctions in HEK293T cells without L1 overexpression. A lack of spanning reads and the tendency of Illumina library preparation to produce artefacts (Treiber and Waddell, 2017) leave this analysis open to interpretation. The application of ONT sequencing to HEK293T cells nonetheless held conceptual merit. ONT reads can span germline and somatic retrotransposition events end-to-end, and resolve the sequence hallmarks of L1-mediated integration (Ewing et al., 2020; Siudeja et al., 2021) . Through this approach, we previously found two somatic L1 insertions in the liver tumour sample of an individual positive for hepatitis C virus (HCV), a ~10kbp positive-sense single-stranded non-polyadenylated RNA virus (Lauer and Walker, 2001) , including one PCR-validated L1 insertion spanned by a single ONT read (Ewing et al., 2020; Shukla et al., 2013) . Moreover, HEK293T cells are arguably a context favourable to L1 activity. They express L1 ORF1p (Philippe et al., 2016) , accommodate engineered L1-mediated retrotransposition in cis and in trans (Hancks et al., 2011; Kubo et al., 2006; Niewiadomska et al., 2007; Sanchez-Luque et al., 2019) , and support SARS-CoV-2 viral replication ( Figure S1 ). Endogenous L1-mediated insertions can be detected in cell culture by genomic analysis of separate cultivars derived from a common population (Klawitter et al., 2016; J o u r n a l P r e -p r o o f al., 2018). Based on this experimental rationale, we sought to replicate the central findings of Zhang et al. and, after deeply ONT sequencing SARS-CoV-2-infected HEK293T cells, did not detect SARS-CoV-2 genomic integration. We ONT sequenced (~54× genome-wide depth, read length N50 ~ 39kbp) genomic DNA harvested from HEK293T cells infected with SARS-CoV-2 at a multiplicity of infection (MOI) of 1.0, as well as mock infected cells (~28× depth, N50 ~ 47kbp) (Figures 2A and S1 , and Table S1 ). As positive controls, we ONT sequenced the tumour and non-tumour liver tissue of a HBV-positive hepatocellular carcinoma patient (Shukla et al., 2013) . HBV is a DNA virus known to be integrated into sites of genomic damage via DNA double-strand break repair (Bill and Summers, 2004) . As negative controls, we used the aforementioned HCV-positive hepatocellular carcinoma samples, and a normal liver sample (Ewing et al., 2020) (Table S1 ). We viewed HCV-infected samples as a suitable negative control because HCV and SARS-CoV-2 are both positive-sense single-stranded RNA viruses, yet HCV is not polyadenylated and is therefore unlikely to attract the L1 machinery, and has not been found to integrate into infected hepatocytes or liver tumour genomes (Fujimoto et al., 2012; Lauer and Walker, 2001) . To these data, we added those of Zhang et al., and then used the Transposons from Long DNA Reads (TLDR) (Ewing et al., 2020) software to call SARS-CoV-2, HBV, HCV and retrotransposon insertions spanned by at least one uniquely aligned ONT read. TLDR detected no SARS-CoV-2, HBV or HCV insertions. In total, TLDR identified 575 non-reference human-specific L1 (L1HS) insertions, which were typically flanked by TSDs with a median length of 14bp ( Figure 2B and Table S2 ). No tumour-specific L1 insertions were found, apart from the two previously detected in the HCV-infected liver tumour (Ewing et al., 2020; Shukla et al., 2013) . Seventy-eight L1 insertions were found only in our SARS-CoV-2 infected HEK293T cells (66) or the mock infected control (12) and produced TSDs with a median length of 14bp ( Figure 2B ). Of the 78 events, 69 (88.5%) were detected by a single spanning read and 13 carried a 3′ transduction (Holmes et al., 1994; Moran et al., 1999) (Table S2) . After random downsampling, the more deeply sequenced SARS-CoV-2 infected HEK293T cells still had more than 2-fold more putative cultivar-specific L1 insertions than the mock infected HEK293T cells. Next, we chose at random 6/69 L1 insertions detected by one spanning read for manual curation and PCR validation. All 6 L1 insertions bore a TSD and a 3′ polyA tract, and integrated at a degenerate L1 EN motif (Figures 2D, 2E and S2A-S2D). Three were 5′ J o u r n a l P r e -p r o o f inverted (Kazazian et al., 1988; Ostertag and Kazazian, 2001) (Figures 2E, S2C and S2D) and one carried a 3′ transduction (Holmes et al., 1994) traced to a mobile (Rodriguez-Martin et al., 2020) full-length non-reference L1HS ( Figure S2C ). Three PCR amplified in the SARS-CoV-2 and mock infected samples (Figures 2D, 2E and S2A) and three did not amplify in either sample (Figures S2B-S2D) . The 6 integration sites were on average spanned by 86 reads not containing the L1 insertion ( Figure S2E ), a ratio (1:86) suggesting the L1s were absent from most cells. An additional analysis revealed 293 putative Alu (291) and SVA (2) insertions specific to either one of the HEK293T populations, with 290 of these found in the SARS-CoV-2 infected cells and 275 (93.9%) detected by a single spanning read ( Table S2 ). The median TSD size for this cohort was 13bp ( Figure 2C ). Altogether, these and earlier (Ewing et al., 2020; Siudeja et al., 2021) experiments show that lone spanning ONT reads can recover bona fide retrotransposition events, and highlight endogenous L1 activity in HEK293T cells lacking L1 overexpression systems. We next tested whether our computational analysis parameters excluded genuine HBV, HCV or SARS-CoV-2 insertions. We directly aligned our ONT reads to the genome of the SARS-CoV-2 isolate (QLD002, GISAID EPI_ISL_407896) used here, as well as to a geographically diverse set of HBV and HCV genomes (Table S1) , and a highly mobile L1HS sequence (Dombroski et al., 1993) . In total, 3.6% of our ONT sequence bases aligned to L1HS, whereas no alignments to the SARS-CoV-2 or HCV genomes were observed ( Figure 3A ). One read from the HBV-infected non-tumour liver sample aligned to 2,770bp of a HBV genotype B isolate, and the remaining 2,901bp aligned to an intergenic region of chromosome 2 ( Figure 3B and Table S2 ). To validate this HBV insertion, we PCR amplified and capillary sequenced its 3′ junction ( Figure 3B ). The HBV sequence was linearised and rearranged ( Figure 3B ) as per prior reports (Fujimoto et al., 2012; Jiang et al., 2012; Nagaya et al., 1987) . Direct inspection of ONT read alignments thus recovered a HBV integrant, which are found in ~1 per 10 1 -10 4 infected hepatocytes (Mason et al., 2016; Tu et al., 2018 ), yet did not reveal reads alignable to the SARS-CoV-2 genome in our ONT datasets. Reanalysing the ONT data generated by Zhang et al., we found 555 reads (out of ~12 million) that generated an alignment of ≥100bp to the SARS-CoV-2 genome ( Figure 3A ). These reads (median length 924bp) were however 65.6% shorter than the overall dataset (2,686kbp) and were comprised of a much higher average proportion of SARS-CoV-2 sequence (52.3%) than the proportion of L1HS sequence found in reads aligned to L1HS (17.1%). Of the 555 reads, 79 generated an alignment of ≥100bp to the human genome, including one matching the aforementioned integrant on chromosome X that lacked a 3′ J o u r n a l P r e -p r o o f polyA tract ( Figure 1A ). An analysis of the corresponding 79 human genome alignment breakpoints, which could be interpreted as putative SARS-CoV-2 insertion points, as per Zhang et al., indicated 36 .2% were exonic ( Figure 3C ). By comparison, 1.1% of all nonreference L1-mediated insertions reported here were exonic (Figure 3C) , as were 1.3% and 1.7% of cultivar-specific L1 and Alu insertions, respectively (Figures 2B and 2C) . Finally, we investigated why TLDR called neither of the two SARS-CoV-2 insertions highlighted by Zhang et al. (Figure 1) , and found ambiguity in the ONT read alignments supporting these examples led to their exclusion. Specifically, the putative chromosome X insertion ( Figure 1A ) was filtered due to its short 5′ genomic flank alignment, whereas the chromosome 22 example was filtered because the corresponding ONT read alignment was marked as supplementary to another alignment on chromosome 1 ( Figure 1B) . These analyses We did not observe L1-mediated SARS-CoV-2 genomic integration in HEK293T cells, despite availability of the L1 machinery (Hancks et al., 2011; Kubo et al., 2006; Niewiadomska et al., 2007; Philippe et al., 2016; Sanchez-Luque et al., 2019) and detected L1, Alu and SVA retrotransposition events. The higher number of L1 and Alu insertions found in our SARS-CoV-2-infected HEK293T cells is of potential interest given viral infection can repress host factors limiting L1 activity (Hrecka et al., 2011; Laguette et al., 2011; Zhao et al., 2013) . This preliminary finding perhaps indicates SARS-CoV-2 infection could increase L1 or Alu retrotransposition in vitro, a possibility requiring experimental confirmation. The comparative rarity of SVA insertions, and absence of SARS-CoV-2 insertions, is however congruent with the relative frequencies of L1, Alu, SVA and nonretrotransposon cellular RNA insertions driven by L1 proteins in prior cultured cell assays (Dewannieux et al., 2003; Hancks et al., 2011; Wei et al., 2001) . Our approach has several notable differences and caveats when compared to that of kit, ~21× depth, N50 ~ 11kbp) and here (Nanobind kit, SQK-LSK110 kit, ~54× depth, N50 ~ J o u r n a l P r e -p r o o f 39kbp) differed. Nevertheless, the DNA extraction protocols of each study would limit retention of extrachromosomal SARS-CoV-2 DNA potentially generated by ectopic L1 reverse transcription (Dhellin et al., 1997) . The origins of the ONT reads aligned to the SARS-CoV-2 genome reported by Zhang et al. are therefore unclear in our view. Zhang et al. only ONT sequenced HEK293T cells transfected with an L1 expression plasmid, which human cells would not carry in vivo. We did not analyse SARS-CoV-2 patient samples although, arguably, HEK293T cells present an environment far more conducive to L1 activity than those cells accessed in vivo by SARS-CoV-2 (Sungnak et al., 2020; Wiersinga et al., 2020) . Widespread cell death post-infection also reduces the probability SARS-CoV-2 integrants would persist in the body (Karki et al., 2021; Varga et al., 2020) . This view aligns with a very recent report of negligible SARS-CoV-2 DNA being detected by PCR in COVID-19 patient nasal swabs (Briggs et al., 2021) . preference strongly disfavours SARS-CoV-2 retrotransposition, making the phenomenon mechanistically plausible but likely very rare, as for other polyadenylated nonretrotransposon cellular RNAs (Dewannieux et al., 2003; Doucet et al., 2015; Esnault et al., 2000; Garcia-Perez et al., 2007; Hancks et al., 2011; Kulpa and Moran, 2006; Monot et al., 2013; Moran et al., 1996; Wei et al., 2001) . The authors declare no competing interests. which were then either SARS-CoV-2 infected or mock infected. DNA was extracted from each cultivar, as well as from hepatocellular carcinoma patient samples, and subjected to ONT sequencing. ONT reads were used to call non-reference L1 and virus insertions with TLDR, which also resolves TSDs and other retrotransposition hallmarks. TSDs: red triangles; polyA tract: green rectangle; ONT read: blue rectangle. Some illustrations are adapted from a previous study (Ewing et al., 2020) . (B) A HBV insertion detected in non-tumour liver. In this example, an ONT read from the non-tumour liver of HCC32 spanned the 3ʹ junction of a HBV integrant located on chromosome 2. Of the HBV isolate genomes considered here, this read aligned best to a representative of genotype B (Genbank accession AB602818). The HBV sequence was rearranged consistent with its linearisation prior to integration (Fujimoto et al., 2012; Jiang et al., 2012; Nagaya et al., 1987) . Numerals indicate positions relative to AB602818. Symbols J o u r n a l P r e -p r o o f (β, δ) represent the approximate position of primers used to PCR validate the HBV insertion. The gel image at right shows the 3ʹ junction PCR results. Ladder band sizes are as indicated. The red filled triangle indicates an on-target product confirmed by capillary sequencing. Repeated attempts to PCR amplify the 5ʹ junction of the HBV integrant did not return an ontarget product, perhaps due to a genomic deletion at the insertion site. (C) Percentages of exonic (black), intronic (grey) and intergenic (blue) genomic alignment breakpoints for ONT reads also aligned to the SARS-CoV-2 genome, and also for the nonreference L1-mediated insertions reported here. Genomic features were annotated according to RefSeq coordinates. Please see Tables S1 and S2 for further information. Requests for further information and for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Geoffrey J. Faulkner (faulknergj@gmail.com) . This study did not generate new unique reagents. Oxford Nanopore Technologies sequencing data generated by this study were deposited in HEK293T cells and African green monkey kidney cells (Vero E6) were maintained in standard Dulbecco's Modified Eagle Medium (DMEM). Culture media were supplemented with sodium pyruvate (11mg/L), penicillin (100U/mL), streptomycin (100μg/mL) (P/S) and 10% foetal calf serum (FCS) (Bovogen, USA). Cells were maintained at 37 ºC with 5% CO 2 . An early Australian SARS-CoV-2 isolate (hCoV-19/Australia/QLD02/2020; GISAID Accession EPI_ISL_407896) was sampled from patient nasopharyngeal aspirates by Queensland Health Forensic and Scientific Services and used to inoculate Vero E6 African green monkey kidney cells (passage 2). A viral stock (passage 3) was then generated on Vero E6 cells and stored at -80ºC. Viral titration was determined by immuno-plaque assay (iPA), as previously described (Amarilla et al., 2021) . To verify viral replication in HEK293T cells, a growth kinetic was assessed using a multiplicity of infection (MOI) of 0.01, 0.1 or 1.0, and showed efficient SARS-CoV-2 replication ( Figure S1 ). HEK293T viral infection was undertaken as follows: 3×10 6 HEK293T cells were seeded onto 6-well plates pre-coated with polylysine one day before infection. Cells were infected at MOI of 1 in 200µL of DMEM (2% FCS and P/S) and incubated for 30min at 37ºC. Plates were rocked every 5min to ensure the monolayer remained covered with inoculum. The inoculum was then removed, and the monolayer washed five times with 1mL of additive-free DMEM. Finally, cells were maintained with 3mL of DMEM (supplemented with 2% foetal bovine serum and P/S) and incubated at 37ºC with 5% CO 2 . Cell supernatant was harvested 0, 1, 2 and 3 days post-infection. The mock infected control differed only in that virus was not added to the inoculum media. Genomic DNA was extracted from mock and SARS-CoV-2 infected (MOI 1.0) HEK293T cells sampled 2 days post-infection, using a Nanobind CBB Big DNA Kit (Circulomics) following the manufacturer's instructions for high molecular weight (HMW) DNA extraction. DNA was eluted in elution buffer (10mM Tris-Cl, pH 8.5) and concentration measured by Qubit dsDNA High-Sensitivity Assay Kit on a Qubit Fluorometer (Life Technologies). J o u r n a l P r e -p r o o f DNA was extracted from the HCC32 tissues in our earlier study (Shukla et al., 2013) with a DNeasy Blood and Tissue Kit (QIAGEN, Germany) and stored at -80ºC. To enrich for HMW DNA, 4.5μg of DNA from the patient HCC32 tumour and non-tumour liver samples was diluted to 75ng/μL in a 1.5mL Eppendorf DNA LoBind tube and processed with a Short Read Eliminator XS Kit (Circulomics) following the manufacturer's instructions. DNA libraries were prepared at the Kinghorn Centre for Clinical Genomics (KCCG) using 3-4μg HMW input DNA, without shearing, and a SQK-LSK110 ligation sequencing kit. 350-500ng of each prepared library was sequenced separately on one PromethION (Oxford Nanopore Technologies) flow cell (FLO-PRO002, R9.4.1 chemistry) ( Table S1 ). SARS-CoV-2 infected HEK293T DNA was sequenced on two flow cells. Flow cells were washed (nuclease flush) and reloaded at 24hr and 48hr with 350-500ng of additional library to maximise output. Bases were called with guppy 4.0.11 (Oxford Nanopore Technologies). To call non-reference insertions with TLDR (Ewing et al., 2020) , ONT reads generated here, by Zhang et al., and by our previous ONT study of human tissues (Ewing et al., 2020) (Table S1 ) were aligned to the human reference genome build hg38 using minimap2 (Li, 2018) version 2.17 (index parameter: -x map-ont; alignment parameters: -ax map-ont -L -t 32) and SAMtools (Li et al., 2009) We used Primer3 (Untergasser et al., 2012) to design PCR primers for 6 L1 insertions found by a single spanning ONT read, using the reference genome and L1HS sequences as inputs ( PCR primers for the HBV insertion 3ʹ junction ( Figure 3B and In response to a recent claim that SARS-CoV-2 can be incorporated into human DNA by Retrotransposition and Crystal Structure of an Alu RNP in the Ribosome-Stalling Conformation An optimized highthroughput immuno-plaque assay for SARS-CoV-2 Unexpected inheritance: multiple integrations of ancient bornavirus and ebolavirus/marburgvirus sequences in vertebrate genomes Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration Assessment of potential SARS-CoV-2 virus N gene integration into human genome reveals no significant impact on RT-qPCR COVID-19 diagnostic testing (medRxiv) Regulation of transposable elements by DNA modifications LINE-mediated retrotransposition of marked Alu sequences Functional differences between the human LINE retrotransposon and retroviral reverse transcriptases for in vivo mRNA reverse transcription Two additional potential retrotransposons isolated from a human L1 subfamily that contains an active retrotransposable element A 3' Poly(A) Tract Is Required for LINE-1 Retrotransposition Human LINE retrotransposons generate processed pseudogenes Cell lineage analysis in human brain using endogenous retroelements Nanopore Sequencing Enables Comprehensive Transposable Element Epigenomic Profiling L1 retrotransposition in the soma: a field jumping ahead Endogenous viruses: insights into viral evolution and impact on host biology Pedigree-based estimation of human mobile element retrotransposition rates Genome-wide de novo L1 Retrotransposition Connects Endonuclease Activity with Replication Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators Distinct mechanisms for trans-mediated mobilization of cellular RNAs by the LINE-1 reverse transcriptase Recombination of retrotransposon and exogenous RNA virus results in nonretroviral cDNA integration Multiple fates of L1 retrotransposition intermediates in cultured human cells Exontrapping mediated by the human retrotransposon SVA Retrotransposition of marked SVA elements by human L1s in cultured cells A new retrotransposable human L1 element from the LRE2 locus on chromosome 1q produces a chimaeric insertion Endogenous non-retroviral RNA virus elements in mammalian genomes Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients Sequence patterns indicate an enzymatic involvement in integration of mammalian retroposons Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes 100-My history of bornavirus infections hidden in vertebrate genomes SARS-CoV-2-Host Chimeric RNA-Sequencing Reads Do Not Necessarily Arise From Virus Integration Into the Host DNA Mobile DNA in Health and Disease Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man Reprogramming triggers endogenous L1 and Alu retrotransposition in human induced pluripotent stem cells A non-retroviral RNA virus persists in DNA form L1 retrotransposition in nondividing and primary human somatic cells Cis-preferential LINE-1 reverse transcriptase activity in ribonucleoprotein particles SAMHD1 is the dendritic-and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx Hepatitis C virus infection Minimap2: pairwise alignment for nucleotide sequences The Sequence Alignment/Map format and SAMtools HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant The specificity and flexibility of l1 reverse transcription priming at imperfect Ttracts High frequency retrotransposition in cultured mammalian cells Exon shuffling by L1 retrotransposition The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinoma Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association Twin priming: a proposed mechanism for the creation of inversions in L1 retrotransposition Activation of individual L1 retrotransposon instances is restricted to cell-type dependent permissive loci The non-autonomous retrotransposon SVA is trans-mobilized by the human LINE-1 protein machinery Integrative genomics viewer Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition LINE-1 Evasion of Epigenetic Repression in Humans L1 retrotransposition is a common feature of mammalian hepatocarcinogenesis A hot L1 retrotransposon evades somatic repression and initiates human colorectal cancer Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma Unraveling the features of somatic transposition in the Drosophila intestine The Landscape of L1 Retrotransposons in the Human Genome Is Shaped by Pre-insertion Sequence Biases and Post-insertion Selection SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes Resolving the prevalence of somatic transposition in Drosophila Hepatitis B virus DNA integration occurs early in the viral life cycle in an in vitro infection model via sodium taurocholate cotransporting polypeptide-dependent uptake of enveloped virus particles Primer3-new capabilities and interfaces Endothelial cell infection and endotheliitis in COVID-19 Coronavirus biology and replication: implications for SARS-CoV-2 Human L1 retrotransposition: cispreference versus trans complementation Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review A new coronavirus associated with human respiratory disease in China Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues Modulation of LINE-1 and Alu/SVA retrotransposition by Aicardi-Goutières syndrome-related SAMHD1 The authors thank the human subjects of this study who donated tissues to the Centre Hépatobiliaire, Paul-Brousse Hospital. We thank S. Richardson and R. Shukla for helpful discussions, K. Chappell and P. Young for project support, and Queensland Health for providing the SARS-CoV-2 virus isolate QLD02. This study was funded by an Australian